All | severe degree of B-lines (≥ 30) in [13] | moderate (15–29) in 33 68.6% | Mild < 15 | P | |
---|---|---|---|---|---|
Age | 75 ± 7.7 | 78 ± 4 | 76 ± 6 | 72 | 0.24 |
Sex (female) (%) | 25 (52%) | ||||
BMI | 27.11 ± 3.8 | 28.22 ± 3.4 | 26.99 ± 4.19 | 25.84 ± 5 | 0.812 |
SBP (mmHg) | 132.82 ± 12 | 140.85 ± 11 | 134.00 ± 14.7 | 127 ± 80 | 0.521 |
DBP (mmHg) | 76.66 ± 8 | 76.71 ± 6 | 76.71 ± 10.8 | 66.8 | 0.977 |
NYHA1 | 13 ± 12 | 0 | 0 | 13 | |
NYHA2 | 19 ± 15 | ||||
NYHA3 | 43 ± 34 | ||||
DM | 37 | 9 | 27 | 1 | 0.45 |
hypertension | 45 | 12 | 31 | 2 | 0.54 |
Furosemide (%) | 2 (4.2) | 1 | 1 | 0 | 0.4 |
Haemoglobin | 13 ± 2 | 11 ± 3 | 14 ± 1 | 12 ± 2 | 0.88 |
Renal impairment (%) | 24 | 8 | 15 | 1 | 0.4 |
Haemodialysis no (%) | 4 | 2 | 2 | 0 | 0.5 |
IHD (%) | 34 (70) | 10 | 22 | 2 | 0.56 |
LVEF (mean) (%) | 60.23 | 44.6 | 43.48 | 56 | 0.346 |
CABG (no) | 34 | 10 | 22 | 2 | 0.56 |
Invasive LVEDP | 28.3 | 30.00 | 26.46 | 25.5 | 0.001 |
E/E’ | 20.59 | 25.53 | 18.87 | 12 | 0.001 |
DT | 228.5 | 209 | 221 | 240 | 0.168 |
E/A | 1.6 | 1.5 | 1.11 | 0.85 | 0.293 |